Fludarabine-mitoxantrone-rituximab regimen in untreated intermediate/high-risk follicular non-Hodgkin's lymphoma: experience on 142 patients. [electronic resource]
Producer: 20131224Description: E273-6 p. digitalISSN:- 1096-8652
- Adult
- Aged
- Aged, 80 and over
- Antibodies, Monoclonal, Murine-Derived -- administration & dosage
- Antineoplastic Agents -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Female
- Follow-Up Studies
- Humans
- Lymphoma, Follicular -- diagnosis
- Male
- Middle Aged
- Mitoxantrone -- administration & dosage
- Neoplasm Grading
- Neoplasm Staging
- Prognosis
- Recurrence
- Retrospective Studies
- Rituximab
- Survival Analysis
- Vidarabine -- administration & dosage
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.